Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome

Szarvas, Nóra and Szilágyi, Ágnes and Csuka, Dorottya and Takács, Beáta and Rusai, Krisztina and Réti, Marienn Györgyi and Wágner, László József and Török, Szilárd and Kelen, Kata and Szabó, Attila and Reusz, György and Prohászka, Zoltán (2016) Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome. MOLECULAR IMMUNOLOGY, 71. pp. 10-22. ISSN 0161-5890

Text Szarvas_Mutations_in_aHUS_2016_Molecular_Immunology_u.pdf Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Abstract Atypical hemolytic uremic syndrome (aHUS) is a rare disorder caused by dysregulation of the complement alternative pathway, and associated with mutations in genes of complement components and regulators. In the recent years several studies have been published describing these mutations, however, no data is available from the Central and Eastern European region. In this study we present a detailed genetic analysis of our 30 patients, hospitalized with the diagnosis of aHUS in the past 7 years. We analyzed the genetic variants of genes CFH, CFI, CD46, THBD, CFB and C3; furthermore the possible effect of mutations that may alter the function or level of factor H protein was also investigated. We identified 27 (12 novel and 15 previously described) potentially disease-causing mutations in the candidate genes in 23 patients. Genetic analysis of family members revealed that in most cases the disease develops in individuals with multiple genetic risk factors, which may explain the low penetrance of the mutations. Here we showed that two novel mutations (p.W198R, p.P1161T) and a previously reported one (p.R1215Q) in CFH caused impaired regulation as indicated by increased lysis in hemolytic test, while four CFH mutations (p.V609D, p.S722X, p.T1216del and p.C448Y) were associated with decreased factor H protein level in serum as determined by allele-specific immunoassay. These results further point to the necessity of complete genetic workup of patients with aHUS and to the importance of functional characterization of novel variations.

Actions (login required)

Edit Item